ALLO-501,ALLO-501A,ALLO-647,Fludarabine,Cyclophosphamide
Allogene
['allogene therap', '$allo']
today we presented expanded phase 1 data from our allo-501/501a trials demonstrating the potential of an "off-the-shelf" car t product to match the durability standard set by commercially available autologous therapies in #lbcl at the #icml lugano meeting. $allo
We are a clinical-stage biotechnology company pioneering the development of allogeneic CAR T(“AlloCAR T™”) products for cancer. Guidelines: https://t.co/QnzUmwSa1w